Chemical Compound Review:
Moexiprilat (3S)-2-[(2S)-2-[[(1S)-1- carboxy-3-phenyl...
Synonyms:
SureCN616776, CHEMBL1201405, AC1L1IVG, CTK8E8826, FT-0672451, ...
- Effects of moexiprilat on oestrogen-stimulated cardiac fibroblast growth. Grohé, C., Kahlert, S., Lóbbert, K., van Eickels, M., Stimpel, M., Vetter, H., Neyses, L. Br. J. Pharmacol. (1997)
- Angiotensin-converting enzyme (ACE) inhibition attenuates insulin-like growth factor-I (IGF-I) induced cardiac fibroblast proliferation. van Eickels, M., Vetter, H., Grohé, C. Br. J. Pharmacol. (2000)
- Angiotensin converting enzyme inhibitors block mitogenic signalling pathways in rat cardiac fibroblasts. van Eickels, M., Grohé, C., Löbbert, K., Stimpel, M., Vetter, H. Naunyn Schmiedebergs Arch. Pharmacol. (1999)
- Tricenter assessment of the efficacy of the ACE inhibitor, moexipril, by ambulatory blood pressure monitoring. White, W.B., Whelton, A., Fox, A.A., Stimpel, M., Kaihlanen, P.M. Journal of clinical pharmacology. (1995)
- Moexipril shows a long duration of action related to an extended pharmacokinetic half-life and prolonged ACE inhibition. Cawello, W., Boekens, H., Waitzinger, J., Miller, U. International journal of clinical pharmacology and therapeutics. (2002)
- Metabolism of Moexipril to Moexiprilat: Determination of In Vitro Metabolism Using HPLC-ES-MS. Kalász, H., Petroianu, G., Tekes, K., Klebovich, I., Ludányi, K., G Ulyás, Z. Medicinal chemistry (Sh⁻ariqah, United Arab Emirates) (2007)
- Pharmacological and toxicological studies of the new angiotensin converting enzyme inhibitor moexipril hydrochloride. Friehe, H., Ney, P. Arzneimittel-Forschung. (1997)
- Moexipril. A review of its use in the management of essential hypertension. Brogden, R.N., Wiseman, L.R. Drugs (1998)
- Monitoring the metabolism of moexipril to moexiprilat using high-performance liquid chromatography- electrospray ionization mass spectrometry. Kóti, J., Háda, V., Petroianu, G., Hasan, M.Y., Tekes, K., Szücs, Z., Kalász, H. Journal of chromatographic science. (2006)
- Preclinical development and characterization of an intravenous dosage form for the ACE inhibitor RS-10029. Visor, G.C., Lin, L.H., Henry, P., Singer, L. Journal of parenteral science and technology : a publication of the Parenteral Drug Association. (1989)